We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Merck KGaA (PK) | USOTC:MKKGY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.28 | 0.86% | 33.00 | 32.37 | 33.63 | 33.09 | 32.95 | 33.028 | 26,714 | 21:30:00 |
From May 2019 to May 2024
By Giulia Petroni
Merck KGaA said Wednesday that it has extended its collaboration with Baylor College of Medicine in Houston to accelerate manufacturing of Baylor's Covid-19 vaccine candidates.
The German pharmaceuticals and chemicals company said the teams will improve the manufacturing platform for the CoV RBD219-N1 vaccine candidate and develop a new manufacturing platform for a second candidate to accelerate the transition to phase-1 clinical trials.
"The goal for the partnership is to develop a manufacturing process and steps that would lead to a scale-up approach suitable for pilot and later industrial production," it said.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
May 27, 2020 10:13 ET (14:13 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Merck KGaA (PK) Chart |
1 Month Merck KGaA (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
